Close

Anti-HPGDS DNA-encoded mAb (DMAb), pVAX1 (DMAb-0387-LY)


All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This product is the plasmid containing an encoded anti-HPGDS DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.

  Add to Cart

Specifications

  • Target
  • HPGDS
  • Vector Name
  • pVAX1
  • Vector Description
  • pVAX1 was originally designed for the development of DNA vaccines. Its eukaryotic DNA sequences limited to the expression of desired sequence so that minimize the possibility of chromosomal integration. This vector has been widely used for the construction of DMAb plasmid.
  • Vector Promoter
  • CMV
  • Vector Tag or Fusion
  • Untagged
  • Delivery Method
  • Transfection
  • Cloning Method
  • Restriction Enzyme ⁄ MCS
  • Constitutive or Inducible System
  • Constitutive
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term.
  • Background
  • DNA-encoded mAb (DMAb) technology is a novel approach for a direct in vivo production of desired biologically active immunoglobulins according to the plasmid DNA delivery into tissue where the delivered plasmid containing an encoded antibody sequence. Compared with the traditional mAb, DMAb can be functionally equivalent with additional advantages such as expression profiles, glycosylation, as well as no reliance on in vivo tissue culture and costly or time-consuming production systems. The DMAb technology may provide a novel, simple, less frequent, cost-effective approach for therapeutics.
Sub CAT. DMAb Clone DMAb Host Target Species DMAb Isotype DMAb Immunogen  
DMAb-0387-LY G172-1138 Mouse IgG1 Hematopoietic Prostaglandin D Synthase
DMAb-0388-LY GST01 Mouse IgG1 Hematopoietic Prostaglandin D Synthase
DMAb-0389-LY P1A12 Mouse IgG2b, κ Hematopoietic Prostaglandin D Synthase
DMAb-0390-LY vpg66 Mouse S.japonicum IgG1 Hematopoietic Prostaglandin D Synthase
DMAb-0406-LY 11C1E136 Rabbit Chemical IgG Hematopoietic Prostaglandin D Synthase
DMAb-0407-LY 11C1E16 Mouse Bacterial IgG1 Hematopoietic Prostaglandin D Synthase
DMAb-0409-LY 15TF2‐1D10 Mouse Human IgG1, κ Hematopoietic Prostaglandin D Synthase
DMAb-0410-LY 16-21 Mouse IgG Hematopoietic Prostaglandin D Synthase
DMAb-0411-LY 172 Mouse IgG Hematopoietic Prostaglandin D Synthase
DMAb-0412-LY 17B6 Mouse S.japonicum IgG1 Hematopoietic Prostaglandin D Synthase
DMAb-0413-LY 1B3 Mouse S.japonicum IgG1 Hematopoietic Prostaglandin D Synthase
DMAb-0414-LY 1E1K22E1 Mouse Chemical IgG Hematopoietic Prostaglandin D Synthase
DMAb-0415-LY 2021 HuCAL Fab Hematopoietic Prostaglandin D Synthase
DMAb-0416-LY 2031 HuCAL Fab Hematopoietic Prostaglandin D Synthase
DMAb-421-YC 3D4 Mouse IgG2b Hematopoietic Prostaglandin D Synthase
DMAb-459-YC 3G10 Mouse IgG1 Hematopoietic Prostaglandin D Synthase
DMAb-0420-LY 5C12 Mouse IgG1 Hematopoietic Prostaglandin D Synthase
DMAb-0421-LY 6D42E1 Mouse S.japonicum IgG1 Hematopoietic Prostaglandin D Synthase
DMAb-0422-LY 6E5 Mouse S.japonicum IgG1 Hematopoietic Prostaglandin D Synthase
DMAb-3441CQ 6G9 Rat S.japonicum IgG2a Hematopoietic Prostaglandin D Synthase
DMAb-0424-LY 8C1-G4 Mouse IgG2b Hematopoietic Prostaglandin D Synthase
DMAb-0425-LY BDI340 Mouse S.japonicum IgG1 Hematopoietic Prostaglandin D Synthase
DMAb-0427-LY GF1 Mouse IgG1 Hematopoietic Prostaglandin D Synthase
DMAb-0428-LY GST.B6 Mouse IgG2a Hematopoietic Prostaglandin D Synthase
DMAb-0429-LY KAB29 Mouse IgG1 Hematopoietic Prostaglandin D Synthase
DMAb-0431-LY L70B11 Mouse IgG1 Hematopoietic Prostaglandin D Synthase
DMAb-0167-CN Mix Mouse IgG Hematopoietic Prostaglandin D Synthase
DMAb-0434-LY PIP Hamster IgG Hematopoietic Prostaglandin D Synthase
DMAb-0435-LY Q16 Mouse IgG Hematopoietic Prostaglandin D Synthase
DMAb-0436-LY Q9 Mouse IgG Hematopoietic Prostaglandin D Synthase
DMAb-0437-LY S-tag-02 Mouse IgG Hematopoietic Prostaglandin D Synthase
DMAb-0438-LY S-tag-05 Mouse IgG2b Hematopoietic Prostaglandin D Synthase
DMAb-0374-LY 21CT54.13.1/21CT54.13.7 Mouse S.japonicum IgG1, κ Hematopoietic Prostaglandin D Synthase
DMAb-0376-LY 26H1 Mouse All Species IgG2a Hematopoietic Prostaglandin D Synthase
DMAb-1215-LY 2A10 Mouse IgG1 Hematopoietic Prostaglandin D Synthase
DMAb-0378-LY 2F10B9 Mouse IgG Hematopoietic Prostaglandin D Synthase
DMAb-0379-LY 2H3-D10 Mouse S.japonicum IgG1 Hematopoietic Prostaglandin D Synthase
DMAb-0380-LY 3937 HuCAL Fab Hematopoietic Prostaglandin D Synthase
DMAb-0381-LY 3H2162 Mouse S.japonicum IgG1 Hematopoietic Prostaglandin D Synthase
DMAb-1048-LY 4C10 Mouse IgG2b Hematopoietic Prostaglandin D Synthase
DMAb-0383-LY 8A169 Mouse Chemical IgG1 Hematopoietic Prostaglandin D Synthase
DMAb-0384-LY 9AT106 Mouse S.japonicum IgG1 Hematopoietic Prostaglandin D Synthase
DMAb-0385-LY E1-T-177 Mouse Chemical IgG Hematopoietic Prostaglandin D Synthase

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-HPGDS DNA-encoded mAb (DMAb), pVAX1 (DMAb-0387-LY). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.